皮内接种灭活猪流感病毒与佐剂PCEP诱导猪的体液和细胞免疫并降低肺部病毒滴度
研究在猪中比较肌内或皮内接种PCEP佐剂灭活猪流感病毒H1N1疫苗的免疫应答。皮内接种刺激显著抗SIV抗体滴度、增加中和抗体,并在强毒H1N1攻击后显著降低肺部病毒载量、有限减少大体肺病变。结果表明PCEP可能作为猪流感病毒疫苗佐剂有效,应被视为未来猪皮内流感疫苗的潜在候选佐剂。
要点
- 皮内接种PCEP佐剂灭活SIV疫苗刺激显著抗SIV抗体滴度和增加中和抗体。
- 皮内接种组在强毒H1N1攻击后显著降低肺部病毒载量,大体肺病变仅有限减少。
- 作者认为PCEP可能作为猪流感病毒疫苗佐剂有效,应被视为未来猪皮内流感疫苗的潜在候选佐剂。
核心结论
- 作者认为PCEP可能作为针对猪流感病毒的有效疫苗佐剂,并应被视为未来猪皮内流感疫苗的潜在候选佐剂。
研究设计与样本
- 研究在猪中评估肌内或皮内接种PCEP佐剂灭活猪流感病毒H1N1疫苗所诱导免疫应答的幅度和类型。
主要发现
- 皮内接种PCEP佐剂灭活SIV疫苗刺激显著抗SIV抗体滴度并增加中和抗体。
- 皮内接种组在强毒H1N1攻击后显著降低肺部病毒载量,大体肺病变仅有限减少,均相对于对照动物。
临床怎么用
- 作者认为PCEP应被视为未来猪皮内流感疫苗的潜在候选佐剂。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Swine influenza virus is endemic worldwide and it is responsible for significant economic losses to the swine industry. A vaccine that stimulates a rapid and long-lasting protective immune response to prevent this infection is highly sought. Poly[di(sodium carboxylatoethylphenoxy)-phosphazene (PCEP) has demonstrated adjuvant activity when formulated as part of multiple vaccines in mice and pigs. In this study we examined the magnitude and type of immune response induced in pigs vaccinated via the intramuscular or intradermal routes with inactivated swine influenza virus (SIV) H1N1 vaccine formulated with PCEP. Intradermal administration of PCEP-adjuvanted inactivated SIV vaccine stimulated significant anti-SIV antibody titres, increased neutralizing antibodies, and significantly reduced lung virus load with limited reduction of gross lung lesions after challenge with virulent H1N1 relative to control animals. These results indicate that PCEP may be effective as a vaccine adjuvant against swine influenza viruses in pigs and should be considered a potential candidate adjuvant for future swine intradermal influenza vaccines.
引用
- Magiri R, Lai K, Chaffey A, et al. Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs. Vaccine. 2018. PMID: 29454517. doi:10.1016/j.vaccine.2018.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。